Poly (ADP-Ribose) Polymerase 2 (PARP2) (C-Term) Peptid
PARP2
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN2181971
Kurzübersicht für Poly (ADP-Ribose) Polymerase 2 (PARP2) (C-Term) Peptid (ABIN2181971)
Target
PARP2
(Poly (ADP-Ribose) Polymerase 2 (PARP2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequenz
- QCNELLEANP KAEGLLQGKH STKGLGKMAP SSAHFVTLNG STVPLGPASD
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PARP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
Poly (ADP-Ribose) Polymerase 2 (PARP2) peptide
PARP2 Reaktivität: Human Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PARP2 (Poly (ADP-Ribose) Polymerase 2 (PARP2))
-
Hintergrund
-
PARP2 is involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks.
Alias Symbols: ADPRT2, ADPRTL2, ADPRTL3, ARTD2, PARP-2, pADPRT-2
Protein Size: 570 -
Molekulargewicht
- 62 kDa
-
Gen-ID
- 10038
-
NCBI Accession
- NM_001042618, NP_001036083
Target
-
Sie sind hier:
